Our previous analysis of ovarian cancer databases revealed that LOC730101 expression tended to be down-regulated with increasing malignancy of ovarian cancer, was highly expressed in platinum-sensitive tissues of ovarian cancer and was positively correlated with prognosis, and that LOC730101 may function as an oncogenic function in ovarian cancer, but studies on the mechanism of action of LOC730101 are superficial and have not been reported in ovarian cancer. Here, ENSG00000291006 is linked to ovarian carcinoma.